We further performed ELISA to clarify the changes in the ALB, ARHGDIB, C3, FCN2, and LPA levels during anti-TB treatment in 57 untreated patients (0 month), 53 2-month treated patients (2 months), and 59 cured patients (>6 months). This evidence concerns the gene C3 and tuberculosis.